| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |